A cobalt-catalyzed site-selective C(sp3)–H bromination via radical relay is reported. The mild and practical protocol uses NBS as the brominating reagent with only 1 mol % CoBr2 as the catalyst and achieves excellent benzylic selectivity (>20:1) over aliphatic C–H bonds, overcoming limitations of conventional bromination methods. It also features a broad substrate scope, good functional group tolerance, and scalability and enables late-stage bromination of complex bioactive natural products and pharmaceutical molecules.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: